Cargando…

Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow‐up fluorine‐18 fluorodeoxyglucose positron emission tomography

Cardiac sarcoidosis (CS) causes lethal arrhythmia and heart failure and has a poor prognosis; therefore, early detection and early stage treatment are important. However, diagnosis of isolated CS may be difficult in some cases owing to the low sensitivity of myocardial biopsy. Herein, we describe th...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Daichi, Kanzaki, Yumiko, Fujita, Shuichi, Inuyama, Maaya, Takashima, Shogo, Miyamura, Masatoshi, Terasaki, Fumio, Hoshiga, Masaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676290/
https://www.ncbi.nlm.nih.gov/pubmed/31264810
http://dx.doi.org/10.1002/ehf2.12472
_version_ 1783440743135707136
author Maeda, Daichi
Kanzaki, Yumiko
Fujita, Shuichi
Inuyama, Maaya
Takashima, Shogo
Miyamura, Masatoshi
Terasaki, Fumio
Hoshiga, Masaaki
author_facet Maeda, Daichi
Kanzaki, Yumiko
Fujita, Shuichi
Inuyama, Maaya
Takashima, Shogo
Miyamura, Masatoshi
Terasaki, Fumio
Hoshiga, Masaaki
author_sort Maeda, Daichi
collection PubMed
description Cardiac sarcoidosis (CS) causes lethal arrhythmia and heart failure and has a poor prognosis; therefore, early detection and early stage treatment are important. However, diagnosis of isolated CS may be difficult in some cases owing to the low sensitivity of myocardial biopsy. Herein, we describe the case of a patient with isolated CS, showing change from negative to positive fluorine‐18 fluorodeoxyglucose ((18)F‐FDG) positron emission tomography (PET) uptake results within 9 months. The patient showed rapid reduction in left ventricular systolic function with sustained ventricular tachycardia. The diagnosis of isolated CS is often under‐recognized in clinical practice because it commonly requires the diagnosis of extracardiac disease in the absence of a positive endomyocardial biopsy. The Japanese Circulation Society recently published guidelines for CS diagnosis stating that isolated CS can be clinically diagnosed with positive (18)F‐FDG PET or (67)Gallium result. In this case, serial follow‐up (18)F‐FDG PET was useful for diagnosing isolated CS.
format Online
Article
Text
id pubmed-6676290
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66762902019-08-06 Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow‐up fluorine‐18 fluorodeoxyglucose positron emission tomography Maeda, Daichi Kanzaki, Yumiko Fujita, Shuichi Inuyama, Maaya Takashima, Shogo Miyamura, Masatoshi Terasaki, Fumio Hoshiga, Masaaki ESC Heart Fail Case Reports Cardiac sarcoidosis (CS) causes lethal arrhythmia and heart failure and has a poor prognosis; therefore, early detection and early stage treatment are important. However, diagnosis of isolated CS may be difficult in some cases owing to the low sensitivity of myocardial biopsy. Herein, we describe the case of a patient with isolated CS, showing change from negative to positive fluorine‐18 fluorodeoxyglucose ((18)F‐FDG) positron emission tomography (PET) uptake results within 9 months. The patient showed rapid reduction in left ventricular systolic function with sustained ventricular tachycardia. The diagnosis of isolated CS is often under‐recognized in clinical practice because it commonly requires the diagnosis of extracardiac disease in the absence of a positive endomyocardial biopsy. The Japanese Circulation Society recently published guidelines for CS diagnosis stating that isolated CS can be clinically diagnosed with positive (18)F‐FDG PET or (67)Gallium result. In this case, serial follow‐up (18)F‐FDG PET was useful for diagnosing isolated CS. John Wiley and Sons Inc. 2019-07-02 /pmc/articles/PMC6676290/ /pubmed/31264810 http://dx.doi.org/10.1002/ehf2.12472 Text en © 2019 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Maeda, Daichi
Kanzaki, Yumiko
Fujita, Shuichi
Inuyama, Maaya
Takashima, Shogo
Miyamura, Masatoshi
Terasaki, Fumio
Hoshiga, Masaaki
Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow‐up fluorine‐18 fluorodeoxyglucose positron emission tomography
title Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow‐up fluorine‐18 fluorodeoxyglucose positron emission tomography
title_full Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow‐up fluorine‐18 fluorodeoxyglucose positron emission tomography
title_fullStr Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow‐up fluorine‐18 fluorodeoxyglucose positron emission tomography
title_full_unstemmed Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow‐up fluorine‐18 fluorodeoxyglucose positron emission tomography
title_short Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow‐up fluorine‐18 fluorodeoxyglucose positron emission tomography
title_sort case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow‐up fluorine‐18 fluorodeoxyglucose positron emission tomography
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676290/
https://www.ncbi.nlm.nih.gov/pubmed/31264810
http://dx.doi.org/10.1002/ehf2.12472
work_keys_str_mv AT maedadaichi caseofisolatedcardiacsarcoidosisdiagnosedbynewlydevelopedabnormaluptakeduringserialfollowupfluorine18fluorodeoxyglucosepositronemissiontomography
AT kanzakiyumiko caseofisolatedcardiacsarcoidosisdiagnosedbynewlydevelopedabnormaluptakeduringserialfollowupfluorine18fluorodeoxyglucosepositronemissiontomography
AT fujitashuichi caseofisolatedcardiacsarcoidosisdiagnosedbynewlydevelopedabnormaluptakeduringserialfollowupfluorine18fluorodeoxyglucosepositronemissiontomography
AT inuyamamaaya caseofisolatedcardiacsarcoidosisdiagnosedbynewlydevelopedabnormaluptakeduringserialfollowupfluorine18fluorodeoxyglucosepositronemissiontomography
AT takashimashogo caseofisolatedcardiacsarcoidosisdiagnosedbynewlydevelopedabnormaluptakeduringserialfollowupfluorine18fluorodeoxyglucosepositronemissiontomography
AT miyamuramasatoshi caseofisolatedcardiacsarcoidosisdiagnosedbynewlydevelopedabnormaluptakeduringserialfollowupfluorine18fluorodeoxyglucosepositronemissiontomography
AT terasakifumio caseofisolatedcardiacsarcoidosisdiagnosedbynewlydevelopedabnormaluptakeduringserialfollowupfluorine18fluorodeoxyglucosepositronemissiontomography
AT hoshigamasaaki caseofisolatedcardiacsarcoidosisdiagnosedbynewlydevelopedabnormaluptakeduringserialfollowupfluorine18fluorodeoxyglucosepositronemissiontomography